Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C Koen

Showing results (1-10 of 4) with videos related to

Pageof 1
Sort By:
Mathematical Biosciences|December 9, 2009
Simulation of Y-chromosomal haplotype dataC Koen, M E D'Amato
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|March 6, 2025
Early Cost-Effectiveness Analysis of Using Whole-Genome Sequencing for Patients With Castration-Resistant Prostate CancerJinjing Fu, Nora Franzen, Eline Aas, et al.
The Lancet. Oncology|October 2, 2025
Assessing pathological response to neoadjuvant therapy in renal cell carcinoma: a systematic review and guidelines for sampling and reporting standards from the International Neoadjuvant Kidney Cancer ConsortiumJames P Blackmur, J C Koen van der Mijn, Anne Y Warren, et al.
Cell Reports. Medicine|March 20, 2024
Targeting of vulnerabilities of drug-tolerant persisters identified through functional genetics delays tumor relapseMengnuo Chen, Sara Mainardi, Cor Lieftink, et al.
Pageof 1

Showing results (1-10 of 4) with videos related to

Sort By:
Pageof 1
Mathematical Biosciences|December 9, 2009
Simulation of Y-chromosomal haplotype dataC Koen, M E D'Amato
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|March 6, 2025
Early Cost-Effectiveness Analysis of Using Whole-Genome Sequencing for Patients With Castration-Resistant Prostate CancerJinjing Fu, Nora Franzen, Eline Aas, et al.
The Lancet. Oncology|October 2, 2025
Assessing pathological response to neoadjuvant therapy in renal cell carcinoma: a systematic review and guidelines for sampling and reporting standards from the International Neoadjuvant Kidney Cancer ConsortiumJames P Blackmur, J C Koen van der Mijn, Anne Y Warren, et al.
Cell Reports. Medicine|March 20, 2024
Targeting of vulnerabilities of drug-tolerant persisters identified through functional genetics delays tumor relapseMengnuo Chen, Sara Mainardi, Cor Lieftink, et al.
Pageof 1